That is 0 articles you have read today.
The Aporia is free and carries no advertising, so readers are the only
thing paying for it. If you are getting this much out of it, a small
donation is what keeps it independent.
Daily limit reached
You have read 0 articles today.
That is more than the 15 a day The Aporia gives away,
and well past what it can carry on nothing. Your allowance resets at
midnight.
There is no advertising here and nothing about you is sold, so readers
are the only thing paying for it. If the site is worth this much of
your day, it is worth a few dollars.
Everything else stays open: the
maps, the
directory and
search do
not count against this, and neither does re-opening something you have
already read today.
Which? found that supplements marketed towards menopausal women, costing up to hundreds of pounds annually, offer no better benefits than a 6p per dose multivitamin. The consumer watchdog reviewed 26 such products and concluded they often lack meaningful doses of key nutrients like calcium, vitamin D, magnesium, iron, B vitamins, and others, while being priced at least 20 times higher than standard supplements. Which? advises consumers to be cautious of marketing claims and suggests that a high-quality multivitamin combined with targeted supplements could be more effective and economical.
Written locally by qwen2.5:14b on 2026-09-30,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Story summary
Which?, a consumer watchdog, found that menopause supplements costing up to £400 annually offer no better benefits than a standard multivitamin priced at 6p per dose. The organization reviewed 26 products from retailers such as Boots, Holland & Barrett, and Amazon, discovering that these supplements often contain key nutrients like calcium and vitamin D in insufficient quantities or omit them entirely. This investigation reveals that many supplements marketed to women experiencing menopause are overpriced and ineffective, suggesting that purchasing a high-quality multivitamin plus targeted supplements could be both cheaper and more effective. The global market for menopause supplements is expected to exceed £18.4 million by 2030, raising concerns about the lack of regulatory oversight in this industry.
Written for “Menopause SupplementsExposedWasteMoney” on 2026-10-05,
grounded in this article and the 2 other(s) covering the same event.
Some supplements marketed at menopausal women and costing hundreds of pounds a year are no better than a 6p a dose multivitamin, a watchdog has said.
asserted
watchdog → market → multivitamin
Many supplements marketed at perimenopausal and menopausal women were overpriced and lacked meaningful doses of key nutrients – while costing 20 times more than a standard multivitamin, researchers for Which? found.
asserted
researchers → market → ?
The consumer group’s nutrition experts reviewed 26 supplements aimed at women going through the perimenopause, menopause or over the age of 45 – cross-checking them with the latest scientific evidence around more than 78 active ingredients.
asserted
experts → review → ingredients
The most important nutrients during menopause are calcium and vitamin D, which support bone health as oestrogen levels decline – while magnesium, iron, B vitamins, vitamins C, E and K, iodine, selenium and zinc can also help women.
asserted
magnesium → support → women
Which? suggested that buying a high-quality multivitamin and adding targeted supplements where needed could be cheaper than a so-called all-in-one menopause blend while being potentially more effective.
uncertain
buying → suggest → blend
Beyond price, many of the menopause supplements also contained key nutrients in doses too low to be beneficial, known as “fairy-dusting”, while others omitted important vitamins and minerals altogether, the study found.
asserted
study → contain → vitamins
Many products combined vitamins and minerals with botanical ingredients, but Which? found that the evidence for botanicals such as black cohosh, soy, and red clover was “mixed” and products often contained them at doses far below those used in clinical trials.
asserted
products → combine → trials
Which? said it was concerned that the supplements industry had become a “wild west” and regulators were not doing enough to get a grip on “dubious marketing” and “unchecked quasi-medical claims from firms apparently seeking to cash in on people’s health anxiety and insecurities”.
uncertain
regulators → say → anxiety
It advised shoppers not to be “swayed” by the marketing of specialist menopause or menopause friendly supplements, and to check what they were actually getting for their money before paying a premium.
asserted
they → advise → premium
nutritionist Shefalee Loth said: “Navigating mid-life is tricky enough but with so many products making big claims about how they can help, finding what actually works can be completely overwhelming and costs can spiral.
uncertain
costs → say → claims
“Our research shows that despite these big claims the vast majority of these products lack the nutritional basics to cover the deficiencies most likely to happen with menopause despite some costing hundreds and hundreds of pounds a year.
uncertain
majority → show → pounds
“Our advice is to look beyond the marketing hype and think carefully about what you actually need.
asserted
you → look → what
A higher price doesn’t automatically mean a product will be effective and a cheap multivitamin could do the same job without breaking the bank.”
uncertain
multivitamin → mean → bank
The Aporia
